Ideas
Large caps benefit from ETF flows.
He says ETF and institutional flows are concentrating in large-cap names, and even with foreign selling in KOSPI, domestic buying is strong, so investors should focus on large caps.
Memory upcycle supports Samsung Electronics.
He argues Samsung Electronics is still in a memory upcycle where DRAM/NAND prices and HBM demand are lifting earnings; although the 260,000 won target may be high, a 200,000 won area is realistic if first-half targets are met, so it should not be sold too early.
HBM and memory drive SK hynix.
He sees SK hynix earnings power improving with HBM and memory shortages; a 1.5 million won target is debated, but if operating profit reaches 150 trillion won, 1 million won is within reach, so it is too early to exit.
KOSDAQ liquidity supports upside.
He cites NH Investment's 1,300 KOSDAQ target and says overheated sentiment could stretch to 1,500; ETF flows and retail liquidity are driving the index, with historical PER extremes supporting upside.
Korean market remains in uptrend.
He argues KOSPI EPS growth is keeping pace with price gains, global liquidity is moving toward non-US markets including Korea, and the market is not yet a place to leave.
Buy KOSDAQ chip equipment and materials.
If investors want semiconductor exposure, he prefers large-cap KOSDAQ semiconductor equipment and materials stocks because money is rotating toward KOSDAQ 150 and those names have higher upside potential than Samsung or SK hynix.
Secondary battery rebound has multiple catalysts.
He says the secondary battery sector is improving as European EV sales surpass gasoline cars, lithium carbonate prices surge, short covering and short squeezes appear, and robot battery narratives add momentum, with LG Energy Solution, EcoPro, EcoPro BM and L&F leading.
LGES ESS data-center demand is real.
He says LG Energy Solution's ESS sales to data centers are becoming real, and EV versus ESS revenue mix may reverse by 2026-2028 at its US plants, while robot battery narratives also support the stock.
Pharma short squeeze is likely.
He sees a higher probability of a short squeeze in KOSDAQ pharmaceutical and biotechnology stocks because positioning is tight and liquidity is rotating into KOSDAQ growth sectors.
Solbrain earnings improvement supports re-rating.
He says Solbrain's earnings improvement is clear even though the report did not raise profit forecasts much, so the stock can re-rate; the conservative 390,000 won target was quickly broken and 400,000 won is achievable at around 20x.
PSK has conservative target upside.
He says PSK Holdings and PSK had earnings forecasts raised in a recent report but target prices were set conservatively, leaving room for the stock to move higher.
Korea Circuit is cheap with upside.
He argues Korea Circuit is relatively cheap versus printed-circuit-board peers, earnings are expected to double, and new reports target 82,000-87,000 won versus the 68,000 won price, so it can continue catching up.
Stablecoin-related selloff is a buy.
He argues the delay in stablecoin legislation hit NAVER, NHN, NHN KCP and KakaoPay, but their fundamentals are not broken and the selloff is a buying opportunity, especially with the bill expected to be revisited before the February holiday.
Lagging chip materials can catch up.
He says BCNC, Woldix and KoMiCo are semiconductor materials names that have lagged, and because materials stocks move last in a cycle, they can catch up in the current liquidity-driven rally.
Entertainment names may rebound.
He notes Pearl Abyss has risen but not as a top pick, and if KOSDAQ 150 money rotates, entertainment names such as YG Entertainment and HYBE, which are near lows, deserve attention.
Korean defense demand is rising.
He highlights Norway's $2 billion long-range precision strike budget and rising geopolitical tensions as support for Korean defense exporters.
Hyundai's Atlas robot drives optimism.
He says Trump's conciliatory tariff comments and the TACO trade reduce auto tariff risk, while GM's strong North America guidance and hybrid demand support Hyundai, Kia and Hyundai Mobis; dips may be buying opportunities.
KOSDAQ policy and flows drive upside.
He says government KOSDAQ support, institutional buying, and concentration in four themes—pharma/biotech, semiconductor equipment/materials, secondary battery, and robots—can push KOSDAQ toward 1,300, with liquidity mattering more than valuation.
Samsung front-end equipment chain benefits.
He says Wonik IPS, Tes and Eugene Technology are Samsung-affiliated front-end semiconductor equipment names that surged on the Samsung value-chain recovery and should benefit from the memory capex cycle.
Doosan Tesna benefits from Exynos yields.
He argues Doosan Tesna benefits as Exynos 2600 yield and utilization improve, creating a direct rebound in test demand.
Korean pharma has multiple catalysts.
He cites Hanmi Pharm's GLP-1 obesity/metabolic drug distribution deal, tariff relief, and strength in Celltrion, Alteogen and LigaChem Bio with a raised target for LigaChem as reasons Korean pharma/biotech is attractive.
Korean memory duo remains undervalued.
He points to SK Securities' raised targets for Samsung Electronics and SK hynix, strong memory price increases, HBM4 allocation news, and still-cheaper valuations than US memory peers, arguing investors should not exit too early.
SOCAMM expands AI memory demand.
He says SOCAMM adoption by Nvidia, Qualcomm and AMD expands LPDDR demand, and Samsung is reported to have won about half of Nvidia's SOCAMM2 volume, making SOCAMM a next HBM-like structural memory theme.
Humanoid batteries boost Korean battery makers.
He says LG Energy Solution is negotiating humanoid robot battery supply with Tesla and Chinese humanoid makers, where NCM advantages over LFP matter, while lithium, cobalt and nickel prices are rising and CATL mine cuts tighten supply.
Nvidia investment boosts Korean robots.
He highlights Nvidia's planned 20 billion won investment in Korean humanoid robot startup Wirobotics, which sparked rallies in Rainbow Robotics, Higen R&M, SPG and SBB Tech.
Korean aesthetics sector is undervalued.
He cites a Hanwha report saying Korean aesthetic/medical device stocks are undervalued because past export and business-suspension risks have faded, foreign tourist demand is rising, and ECM skin boosters/injectables are growing; PharmaResearch also has record earnings.
Government roadmaps point to three sectors.
He says the government's February-March plans for a bio industry roadmap, manufacturing AI 2030 strategy, and next-generation power semiconductor roadmap explicitly point to sectors to watch.
Holding companies may re-rate.
He says a Kiwoom report argues holding companies will evolve from simple control vehicles into group head companies preparing new growth, and governance reform can drive a re-rating; CJ, SK and GS are named as movers.
Korean market re-rating is structural.
He argues the Korean market rise is not a simple liquidity bubble: governance reform, very cheap valuation versus developed and emerging markets, and improving corporate fundamentals, especially semiconductors, support a longer upcycle with only temporary corrections.
Start with index ETFs, then sectors.
He recommends asset allocation first, then index ETFs such as S&P 500, Nasdaq, KOSPI 200 and KOSDAQ 150, before moving to sector ETFs and individual stocks.
Korean memory still cheap versus global peers.
He says Samsung Electronics and SK hynix remain undervalued versus Micron, TSMC and Nvidia, and if MSCI developed-market inclusion or an SK hynix ADR listing happens, the valuation gap can narrow; memory price momentum is the key barometer.
MSCI inclusion could force Korean inflows.
He argues Korea must open FX trading and enter the MSCI developed-market index; because global pension funds benchmark to MSCI, inclusion would force large passive inflows into Korean equities and support the won.
European banks lack structural appeal.
He argues Europe's bank-centric financial system has produced weak capital markets and uncompetitive banks; the top 10 European banks' combined market cap is below JPMorgan's, so the sector lacks structural appeal.
EU savings plan may boost tech.
He says Europe's Savings and Investment Union plan aims to mobilize 10 trillion euros of idle bank deposits into European tech, VC and IPO markets, which could create an alternative growth playground to US tech, though execution faces many hurdles.
Europe needs to fund defense industry.
He says Europe must build its defense industry because of the Russia threat, but traditional bank-deposit funding is insufficient; the SIA/28th regime efforts are partly aimed at mobilizing capital for defense and tech.
Power grid and HVDC investment needed.
He argues Korea needs massive power-grid and HVDC investment for the Yongin semiconductor cluster and renewable energy, and using roads/railways for underground transmission can reduce public opposition and combined construction costs, creating a structural infrastructure theme.
This 3PRO TV (삼프로TV) video, published January 28, 2026,
features Lee Jae-kyu, Kim Jang-yeol, Park Geun-hyung, Lee Chang-hoon, Sohn Jin-seok, Kim Sang-hoon
discussing Korean large-cap stocks, 005930.KS, 000660.KS, KRX:KOSDAQ, KRX:KOSPI, KOSDAQ 150 semiconductor equipment/materials, 373220.KS, 086520.KQ, 247540.KQ, L&F, KOSDAQ Pharma/Biotech sector, Solbrain, 067310.KQ, PSK, 007810.KS, 035420.KS, 181710.KS, 060250.KQ, 377300.KS, 146320.KQ, 101160.KQ, 183300.KQ, 263750.KQ, 122870.KQ, 352820.KS, Korean defense sector, 005380.KS, 000270.KS, 012330.KS, 240810.KQ, 095610.KQ, 084370.KQ, 131970.KQ, 128940.KS, 068270.KS, 196170.KQ, 141080.KQ, MU, 277810.KQ, 160190.KQ, 058610.KQ, 389500.KQ, 214450.KQ, 145020.KQ, 214150.KQ, 278470.KS, Korean bio sector, Korean AI manufacturing, Korean power semiconductors, 001040.KS, 034730.KS, 078930.KS, SPY, QQQ, KOSPI 200, KOSDAQ 150, Korean equities, EUFN, European technology sector, European defense sector, HVDC/power grid infrastructure.
36 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Jae-kyu,
Kim Jang-yeol,
Park Geun-hyung,
Lee Chang-hoon,
Sohn Jin-seok,
Kim Sang-hoon
· Tickers:
Korean large-cap stocks,
005930.KS,
000660.KS,
KRX:KOSDAQ,
KRX:KOSPI,
KOSDAQ 150 semiconductor equipment/materials,
373220.KS,
086520.KQ,
247540.KQ,
L&F,
KOSDAQ Pharma/Biotech sector,
Solbrain,
067310.KQ,
PSK,
007810.KS,
035420.KS,
181710.KS,
060250.KQ,
377300.KS,
146320.KQ,
101160.KQ,
183300.KQ,
263750.KQ,
122870.KQ,
352820.KS,
Korean defense sector,
005380.KS,
000270.KS,
012330.KS,
240810.KQ,
095610.KQ,
084370.KQ,
131970.KQ,
128940.KS,
068270.KS,
196170.KQ,
141080.KQ,
MU,
277810.KQ,
160190.KQ,
058610.KQ,
389500.KQ,
214450.KQ,
145020.KQ,
214150.KQ,
278470.KS,
Korean bio sector,
Korean AI manufacturing,
Korean power semiconductors,
001040.KS,
034730.KS,
078930.KS,
SPY,
QQQ,
KOSPI 200,
KOSDAQ 150,
Korean equities,
EUFN,
European technology sector,
European defense sector,
HVDC/power grid infrastructure
